替吉奧聯(lián)合奧沙利鉑治療晚期結腸癌的效果觀察
打開文本圖片集
【摘要】目的:分析替吉奧聯(lián)合奧沙利鉑治療晚期結腸癌的效果。方法:選取我院2020年1月—2022年12月的70例晚期結腸癌患者,隨機將其分成為兩組。對照組采取奧沙利鉑,觀察組聯(lián)合采取替吉奧。結果:觀察組的有效率為57.14%與對照組的42.86%相比,觀察組有效率明顯較高(P
【關鍵詞】替吉奧;奧沙利鉑;晚期結腸癌
Effect of S-1 combined with oxaliplatin in the treatment of advanced colon cancer
LI Yudong
Longxi County First People’s Hospital of Gansu Province, Longxi, Gansu 748100, China
【Abstract】Objective: To analyze the effect of S-1 combined with oxaliplatin in the treatment of advanced colon cancer. Methods: A total of 70 patients with advanced colon cancer in our hospital from January 2020 to December 2022 were selected and randomly divided into a control group and an observation group. The control group was treated with oxaliplatin, and the observation group was treated with S-1. Results: The effective rate of the observation group was 57.14%, which was significantly higher than 42.86% of the control group(P
【Key Words】 S-1; Oxaliplatin; Advanced colon cancer
結腸癌屬于一種比較常見的消化道惡性腫瘤,在全球范圍內都有較高的發(fā)病率,不但會使患者產生腹痛、消瘦和血便等癥狀,且隨著病情的不斷進展,發(fā)展到晚期時會威脅其生命安全[1]。(剩余4261字)